Eyestem Research announced positive results from its phase 1 trial ( NCT06394232) evaluating its investigational drug product ...

Congenital ectopia lentis is a rare ocular disease characterized by the dislocation or displacement of the lens.

The partnership will integrate Ocuco’s optical software solution, Acuitas 3, with Nextech’s Ophthalmic Platform.

Topline data from both Phase 3 trials is expected in the second quarter of 2026, with NDA submission to follow thereafter.

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

A study analyzed the geographic and institutional disparities in clinical trial distribution for candidates targeting the ...

The announcement follows the decision to discontinue the COAST and ShORe trials in wet age-related macular degeneration after ...

In the European Union and United Kingdom, aflibercept 8 mg (Eylea HD in the US) is currently approved for neovascular ...

The FDA has accepted the resubmission of the biologics license application (BLA) for ONS-5010 (bevacizumab-vikg) for the ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic ...

Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health ...